Sipuleucel-T

• Description:

  Sipuleucel-T is a cancer vaccine. Sipuleucel-T recognizes prostatic acid phosphatase (PAP), present PAP antigens, and stimulates the immune response against prostate cancer cells[1].

• UNSPSC:

  12352100

• Target:

  Phosphatase

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Cancer; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/sipuleucel-t.html

• Smiles:

  [Sipuleucel-T]

• References & Citations:

  [1]Handy CE, et al., Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions. Future Oncol. 2018 Apr;14 (10) :907-917. doi: 10.2217/fon-2017-0531. Epub 2017 Dec 20.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  Phase 3

• CAS Number:

  917381-47-6